Zydus Lifesciences Limited Ofloxacin Export Data — India (DGFT 2022–2026)

Name: Zydus Lifesciences Limited Ofloxacin Export Records India — #15 Exporter, 96 Shipments, $3.4M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Ofloxacin

India Pharmaceutical Trade Intelligence

$295.2M1,094 Suppliers180 CountriesHS 30049099

ExportsIndia → UNITED STATES39.2%India → VIETNAM6.8%

ImportsMALTA → India$59.6M CHINA → India$17.1M

#1 Buyer: DR REDDYS

Zydus Lifesciences Limited — Ofloxacin Exporter #15 | $3.4M Trade Value | TransData Nexus | TransData Nexus

Zydus Lifesciences Limited — Ofloxacin Exporter Profile

Indian Pharmaceutical Exporter · #15 for Ofloxacin · $3.4M export value · DGFT Verified

Zydus Lifesciences Limited is the #15 Indian exporter of Ofloxacin with $3.4M in export value and 96 verified shipments. Zydus Lifesciences Limited holds a 1.2% market share in Ofloxacin exports across 14 countries. The company exports 81 pharmaceutical products worth $346.3M across 25 therapeutic categories.

Zydus Lifesciences Limited — Ofloxacin Export Profile: Buyers & Destinations

Zydus Lifesciences Limited Ofloxacin export treemap — buyers and destination countries | TransData Nexus

Where Does Zydus Lifesciences Limited Export Ofloxacin?

Country	Value	Shipments	Share
UNITED STATES	$933.8K	56	29.3%
SRI LANKA	$846.8K	34	26.6%
UGANDA	$266.5K	8	8.4%
KENYA	$255.4K	11	8.0%

Who Are the Top Buyers of Ofloxacin from Zydus Lifesciences Limited?

Buyer	Country	Value	Orders
EVERSANA LIFE SCIENCE SERVICES	UNITED STATES	$933.8K	56
SUNSHINE HEALTHCARE LANKA LIMITED	SRI LANKA	$846.8K	34
ABACUS PHARMA (AFRICA) LTD	UGANDA	$224.0K	11
ABACUS PHARMA (AFRICA) LTD.	UGANDA	$150.0K	3
ZYDUS NIKKHO FARMACEUTICA LTDA	BRAZIL	$118.3K	4
ZYDUS NIKKHO FARMACEUTICA LTDA.,	BRAZIL	$93.5K	3
LABORATORIOS COMBIX SLU	SPAIN	$74.7K	4
ZYDUS HEALTHCARE SA (PTY) LTD	SOUTH AFRICA	$65.9K	4
ABACUS PHARMA (AFRICA) LIMITED	UGANDA	$60.7K	2
CENTRE SP CIALIT S PHARMACEUTIQUES	FRANCE	$56.1K	2

Zydus Lifesciences Limited supplies Ofloxacin to 29 buyers globally. The largest buyer is EVERSANA LIFE SCIENCE SERVICES (UNITED STATES), followed by SUNSHINE HEALTHCARE LANKA LIMITED (SRI LANKA) and ABACUS PHARMA (AFRICA) LTD (UGANDA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Ofloxacin Formulations Does Zydus Lifesciences Limited Export?

Product Description / Formulation	Value	Shipments
CIPROBID 500MG TABLETS (CIPROFLOXACIN HC	$319.4K	16
CIPROBID 500MG TABS (CIPROFLOXACIN HCL)	$314.5K	8
CIPROBID 500MG TABLETS(CIPROFLOXACIN HCL	$159.1K	6
LEVOFLOXACIN TABLETS USP 500 MG - 1 X 50	$136.9K	4
CIPROBID 500MG TABLETS (CIPROFLOXACIN HCL) 10X10 T	$93.1K	2
LEVOFLOXACIN TABLETS USP 750MG (LEVOFLOXACIN) [40123 PACK X 1X5] (BATCH NO. M501464 & M501465 MFG. DT. 01/2025 EXP.DT. 1	$77.3K	2
LEVOFLOXACIN 500 MG TABLETS	$76.4K	3
CIPROBID 500MG TABLETS(CIPROFLOXACIN HCL)(10 X 10 T)	$68.0K	3
PHARMACEUTICALS MEDICINE FOR HUMAN USE-LEVOFLOXACIN TABLETS USP 750 MG-1X20-QTY-46,512.000 PAC-AS PER INVOICE	$65.9K	3
LEVODAY 500MG TABS (LEVOFLOXACIN TABS 500MG) 2X5 T	$53.9K	3

Zydus Lifesciences Limited exports 87 distinct Ofloxacin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is CIPROBID 500MG TABLETS (CIPROFLOXACIN HC with 16 shipments worth $319.4K.

How Does Zydus Lifesciences Limited Compare to Nearest Ofloxacin Exporters?

Exporters ranked immediately above and below #15 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
10	FDC LIMITED	$5.5M	110	5	$50.0K
1	DR.REDDY'S LABORATORIES LTD	$3.7M	74	2	$50.0K
15	ZYDUS LIFESCIENCES LIMITED ★	$3.4M	96	14	$35.6K
8	MEDOPHARM	$3.1M	62	15	$50.0K
13	MEDCELL PHARMA	$1.9M	38	4	$50.0K

Zydus Lifesciences Limited ranks #15 among 1094 Indian Ofloxacin exporters. Average shipment value of $35.6K compared to the market average of $65.6K. The closest competitors by value are FDC LIMITED and DR.REDDY'S LABORATORIES LTD.

Which Indian Ports Ship Ofloxacin Exports?

Port	Shipments	% Share
SAHAR AIR CARGO ACC (INBOM4)	1,841	12.3%
DELHI AIR CARGO ACC (INDEL4)	1,504	10.0%
SAHAR AIR	1,292	8.6%
NHAVA SHEVA SEA (INNSA1)	1,262	8.4%
DELHI AIR	894	6.0%
Bombay Air	655	4.4%
JNPT/ NHAVA SHEVA SEA	645	4.3%
Delhi Air	361	2.4%

Geopolitical & Trade Policy Impact on Zydus Lifesciences Limited's Ofloxacin Exports

Zydus Lifesciences's export operations are influenced by various geopolitical factors. The Israel-Iran tensions have led to disruptions in Red Sea shipping routes, increasing shipping costs and transit times for Indian exporters. This situation necessitates strategic logistics planning to mitigate potential delays and cost escalations.

Conversely, U.S.-China trade tensions have opened opportunities for Indian pharmaceutical companies like Zydus to capture a larger share of the U.S. market, as American importers seek alternative suppliers. Zydus's recent FDA approvals, including Niacin ER Tablets and Leuprolide Acetate injection, position the company to capitalize on this shift. (ainvest.com)

In the European Union, compliance with the Falsified Medicines Directive (FMD) is crucial for market access. Zydus's proactive measures to align with these regulations enhance its credibility and competitiveness in the EU market. However, the ongoing Israel-Iran conflict poses risks to Middle East trade routes, potentially affecting Zydus's operations in that region.

Zydus Lifesciences Limited — Regulatory Compliance & Quality Standards

Maintaining stringent quality standards is paramount for Zydus Lifesciences. In October 2025, the company received an Establishment Inspection Report (EIR) with a Voluntary Action Indicated (VAI) status from the U.S. FDA for its Baddi manufacturing facility, indicating compliance with regulatory standards. (bajajbroking.in) Similarly, the Ahmedabad SEZ-II facility received a clean USFDA report in November 2025, further affirming the company's commitment to quality. (bajajbroking.in)

These regulatory approvals are critical, as non-compliance can lead to import bans and reputational damage. Zydus's adherence to Good Manufacturing Practices (GMP) and proactive engagement with regulatory bodies underscore its dedication to maintaining high-quality standards across its operations.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Ofloxacin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Zydus Lifesciences Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 165 individual customs records matching Zydus Lifesciences Limited exporting Ofloxacin, covering 87 formulations to 16 countries via 29 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 180+ countries, 3,093+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Ofloxacin

Ofloxacin

Zydus Lifesciences Limited — Ofloxacin Exporter Profile

Zydus Lifesciences Limited — Ofloxacin Export Profile: Buyers & Destinations

Where Does Zydus Lifesciences Limited Export Ofloxacin?

Who Are the Top Buyers of Ofloxacin from Zydus Lifesciences Limited?

What Is India's Total Ofloxacin Export Value and How Much Does Zydus Lifesciences Limited Contribute?

What Is the Average Shipment Value for Zydus Lifesciences Limited's Ofloxacin Exports?

How Does Zydus Lifesciences Limited Compare to Other Indian Ofloxacin Exporters?

What Ofloxacin Formulations Does Zydus Lifesciences Limited Export?

Regulatory Requirements: Exporting Ofloxacin to Key Markets

United States — FDA

How Does Zydus Lifesciences Limited Compare to Nearest Ofloxacin Exporters?

Which Indian Ports Ship Ofloxacin Exports?

Geopolitical & Trade Policy Impact on Zydus Lifesciences Limited's Ofloxacin Exports

Zydus Lifesciences Limited — Regulatory Compliance & Quality Standards

About Zydus Lifesciences Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Ofloxacin Export Data from Zydus Lifesciences Limited

Ofloxacin Stats

Company Overview

Top Products by Zydus Lifesciences Limited

Related Analysis

Need Detailed Export Data?

Data Source